What is the Registry?

The University of Louisville is sponsoring a patient registry for the Ablation of Any Soft Tissue Tumor. Centers interested in participating must currently have an Institutional Review Board. Institutional approval and patient consent will be required at each institution for data enrollment.

Goal and Aims of Registry?

The Specific Aims are:

  • Gain a better understanding of the uses of ablation in the treatment of unresectable soft tissue tumors
  • Understand the limitations, concerns, and complications that earlier users of ablation in the treatment of unresectable soft tissue tumors have
  • Identify the next important question that should be answered through a clinical trial
  • Create a multi-institutional group that will both enroll in this registry study, but more importantly enroll in future, prospective ablation in the treatments of unresectable soft tissue tumors studies

What Patients are Eligible?

  • Any patient to which the treating physician believes that ablation of their soft tissue would be feasible in the care of their disease.
  • Patients with cancers of the:
    • Liver
    • Pancreas
    • Kidney
    • Lung
    • Prostate
    • Retroperitoneum
    • Other
  • Patients who can be followed and can provide outcome data to achieve the Goals and Aims of the Registry.

How do Centers get involved?

Please contact Dr Robert Martin, Registry Principle Investigator; Associate Professor of Surgery at robert.martin@louisville.edu or Dr Govindarajan Narayanan, Co- Registry Principle Investigator; Associate Professor of Clinical Radiology at GNarayanan@med.miami.edu or Dr Jaime Wong, Co- Registry Principle Investigator; Board Certified Urologist at jwong@maliziaclinic.org

Dr. Martin is Division Director of the Division of Surgical Oncology, Associate Professor in the Department of Surgery and faculty member of the University of Louisville James Graham Brown Cancer Center. Dr. Martin received his M.D. from the University of Louisville School of Medicine, and his B.S. from Georgetown University in Mathematics. Dr. Martin joined the staff at the James Graham Brown Cancer Center after completing a two year surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Martin's clinical interests are focused on the multiple disciplinary care and surgical management of patients with upper GI malignancies, including esophageal, gastric, duodenal, liver, biliary, and pancreatic cancers. His research focus is on the genetic predispositions to upper GI malignancies and how they relate to environmental exposure.

Dr. Narayanan is the Chief of the Vascular Interventional Radiology and Associate Professor of Clinical Radiology, at the University of Miami, Miller School of Medicine. He is a Board certified Radiologist with a Certificate of Added Qualification (CAQ) in Interventional Radiology. Prior to his Radiology Residency at St.Barnabas Medical Center in NJ, Dr. Narayanan completed a residency in Nuclear Medicine at Memorial Sloan Kettering Cancer Center. He completed his Interventional Radiology Fellowship at the Medical University of South Carolina. Interventional Oncology is one of his main clinical interests, with emphasis on transarterial and percutaneous treatment of malignancies of the liver.

Dr. Wong is a Board Certified urologist at the Malizia Clinic in Atlanta, GA. He received his Doctor of Medicine degree at Dalhousie University in Halifax, Nova Scotia, Canada followed by postgraduate residency training in Urology at the same institution. He then performed a Fellowship in Laparoscopic Urology at McMaster University in Hamilton, Ontario, Canada. Dr. Wong specializes in endourologic, laparoscopic, robotic and energy ablation surgery. His main clinical focus is prostate cancer and kidney cancer and has a special interest in the incorporation of advanced technology to treat these malignancies minimally invasively.